stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. EQ
    stockgist
    HomeTop MoversCompaniesConcepts
    EQ logo

    Equillium, Inc.

    EQ
    NASDAQ
    Healthcare
    Biotechnology
    La Jolla, CA, US35 employeesequilliumbio.com
    $1.97
    -0.07(-3.43%)

    Mkt Cap $70M

    $0.29
    $2.47

    52-Week Range

    At a Glance

    AI-generated

    Equillium, Inc.

    Revenue breakdown: Research And Development Services (68.9%), Upfront Payment Amortization (31.1%).

    8-K
    Equillium, Inc. announced a private placement of unregistered securities, including pre-funded warrants to purchase common stock, relying on exemptions from registration under the Securities Act of 1933 and state securities laws. The company expects to use net proceeds, together with existing cash, to fund operations.

    $70M

    Market Cap

    $4M

    Revenue

    -$24M

    Net Income

    Employees35
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Research And Development Services68.9%($28M)
    Upfront Payment Amortization31.1%($13M)
    Activity

    What Changed Recently

    Material Agreement
    Mar 12, 2026

    have not been registered under the Securities Act of 1933, as amended (“Securities Act”), or any state securities laws. The Company is relying on the exemption

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    IPSCCentury Therapeutics, Inc...$2.15-2.05%$186M-21.4
    FBIOFortress Biotech, Inc.$2.56+3.64%$79M20.4
    OSTXOS Therapies Incorporated$1.37+0.74%$48M—
    TELOTelomir Pharmaceuticals, ...$1.27-3.79%$44M-4.2
    COEPCoeptis Therapeutics Hold...$11.94+5.85%$42M-3.9
    SPRBSpruce Biosciences, Inc.$71.00+2.11%$41M-1.2
    NRXPNRx Pharmaceuticals, Inc.$2.20+1.85%$38M-1.0
    CUECue Biopharma, Inc.$0.18-11.20%$14M-1.1
    Analyst View
    Company Profile
    CIK0001746466
    ISINUS29446K1060
    CUSIP29446K106
    Phone858 412 5302
    Address2223 Avenida De La Playa, La Jolla, CA, 92037, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice